Healthcare - Biotechnology - NASDAQ - US
$ 9.17
-12.6 %
$ 626 M
Market Cap
-4.61
P/E
Price Target
Average
198.07%
Revenue Forecast
Estimate
61.11%
EBIT
Estimate
--43.23%
Net Income
Estimate
73.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
EyePoint Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for EYPT of $27.3 , with forecasts ranging from a low of $22 to a high of $30 .
EYPT Lowest Price Target
Wall Street Target
22 USD
139.91%
EYPT Average Price Target
Wall Street Target
27.3 USD
198.07%
EYPT Highest Price Target
Wall Street Target
30 USD
227.15%
REVENUE FORECAST
Revenue Forecast Chart EYPT
EBIT FORECAST
EBIT Forecast Chart EYPT
NET INCOME FORECAST
Net Income Chart EYPT